[Hypertension].
The year 2016 has been impacted essentially by the results of the SPRINT trial published in the end of 2015. This study proposed a systolic blood pressure target of <120 mmHg for all high cardiovascular risk patients. In this review, we shall discuss the impact of this trial and the criticisms that have appeared following its publications. These latter will probably limit its practical application. Moreover, we shall discuss the screening of hypertension in children and adolescents and the possible role of drugs lowering uric acid in hypertensive patients with hyperuricemia.